These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Heart failure in the diabetic patient. Bell DS Cardiol Clin; 2007 Nov; 25(4):523-38; vi. PubMed ID: 18063157 [TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease. Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451 [TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus and cerebrovascular disease: which are the actual data? Hatzitolios AI; Didangelos TP; Zantidis AT; Tziomalos K; Giannakoulas GA; Karamitsos DT J Diabetes Complications; 2009; 23(4):283-96. PubMed ID: 18358748 [TBL] [Abstract][Full Text] [Related]
10. [Diabetic cardiomyopathy. Concept, current knowledge and perspectives]. Orozco GP; Manfroi WC Arq Bras Cardiol; 1994 Dec; 63(6):507-11. PubMed ID: 7605238 [No Abstract] [Full Text] [Related]
11. [Diabetic cardiomyopathy]. Cohen A Arch Mal Coeur Vaiss; 1995 Apr; 88(4):479-86. PubMed ID: 7646266 [TBL] [Abstract][Full Text] [Related]
12. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Sorrentino SA; Bahlmann FH; Besler C; Müller M; Schulz S; Kirchhoff N; Doerries C; Horváth T; Limbourg A; Limbourg F; Fliser D; Haller H; Drexler H; Landmesser U Circulation; 2007 Jul; 116(2):163-73. PubMed ID: 17592079 [TBL] [Abstract][Full Text] [Related]
13. A lesson in moderation: applying pharmacodynamics to clarify the relationship between thiazolidinediones and adverse vascular outcomes in type 2 diabetes. Lehmann DF; Lohray BB J Clin Pharmacol; 2008 Aug; 48(8):999-1002. PubMed ID: 18650500 [No Abstract] [Full Text] [Related]
14. [Diabetic autonomic myocardiodystrophy (a review of the foreign literature)]. Vasiukova EA; Minkin SA Klin Med (Mosk); 1986 Apr; 64(4):9-15. PubMed ID: 3523033 [No Abstract] [Full Text] [Related]
15. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Hayat SA; Patel B; Khattar RS; Malik RA Clin Sci (Lond); 2004 Dec; 107(6):539-57. PubMed ID: 15341511 [TBL] [Abstract][Full Text] [Related]
16. Dual PPAR alpha/gamma agonists: promises and pitfalls in type 2 diabetes. Ahmed I; Furlong K; Flood J; Treat VP; Goldstein BJ Am J Ther; 2007; 14(1):49-62. PubMed ID: 17303976 [TBL] [Abstract][Full Text] [Related]
17. Diabetic cardiomyopathy revisited. Boudina S; Abel ED Circulation; 2007 Jun; 115(25):3213-23. PubMed ID: 17592090 [TBL] [Abstract][Full Text] [Related]
18. Frequency of undiagnosed and untreated diabetes mellitus in patients with acute coronary syndromes. Conaway DG; O'Keefe JH Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):503-7. PubMed ID: 16918268 [TBL] [Abstract][Full Text] [Related]
19. Serum insulin concentrations and anticipatory factors of cardiomyopathy in NIDDM. Hockaday TD Diabete Metab; 1987 Jul; 13(3 Pt 2):354-8. PubMed ID: 3308564 [TBL] [Abstract][Full Text] [Related]
20. Sexual dysfunction in women with diabetes mellitus. Rutherford D; Collier A Gynecol Endocrinol; 2005 Oct; 21(4):189-92. PubMed ID: 16316838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]